MorphoSys offers $1.7bn for Constellation, but investors see starsShares in German biotech MorphoSys have gone on the slide after it announced a $1.7 billion deal to Share XMorphoSys offers $1.7bn for Constellation, but investors see starshttps://pharmaphorum.com/news/morphosys-offers-1-7bn-for-constellation-but-investors-see-stars/
CTI wins over FDA to claim early review of myelofibrosis drugShares in US biotech CTI BioPharma have shot up after the FDA agreed to an accelerated review early Share XCTI wins over FDA to claim early review of myelofibrosis drughttps://pharmaphorum.com/news/cti-wins-over-fda-to-claim-early-review-of-myelofibrosis-drug/
Celgene scores regulatory win ahead of BMS mergerCelgene has scored a major regulatory win ahead of its proposed merger with Bristol-Myers Squibb, with the FDA Share XCelgene scores regulatory win ahead of BMS mergerhttps://pharmaphorum.com/news/celgene-scores-regulatory-win-ahead-of-bms-merger/
